Viewing nowCombinationZyduo 5/850 mg Tablet
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.

MFDS item code 201600386 · Approved 2016.01.21 · Insurance code 653501550
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps control blood sugar in adults with type 2 diabetes by combining empagliflozin and metformin. It is used as an adjunct to diet and exercise therapy. It is particularly suitable for patients whose blood sugar is not adequately controlled and should be used with caution in patients with cardiovascular disease. The risk of cardiovascular events should be assessed in consultation with a specialist, and precautions must be checked. This medication improves blood sugar control and is effectively used in diabetes management.
The recommended dose of this medication is 1 tablet per dose, 2 times daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg 2 times daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If a dose of this medication is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, given as 500 mg 2 times daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, discontinue this medication immediately (see Precautions for Use 2. Patients in Whom This Medication Is Contraindicated, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication helps lower blood sugar; however, there are several precautions to be aware of when taking it. First, this medication can cause a rare but serious side effect called lactic acidosis, which can be life-threatening; symptoms should be reported to a doctor immediately. Second, when used in conjunction with insulin or sulfonylureas, hypoglycemic symptoms may occur, so blood sugar levels must be monitored closely. Third, this medication should not be used in patients with impaired kidney function, acute kidney issues, severe infections, heart failure, acute myocardial infarction, or other severe conditions. Fourth, when undergoing tests with iodinated contrast agents, this medication should be temporarily discontinued before and after the procedure, and kidney function must be confirmed to be normal before resuming. Fifth, it is safer for pregnant women, women of childbearing age, or nursing mothers not to take this medication. Sixth, during the course of taking this medication, attention should be paid to dehydration or fluid loss; symptoms such as vomiting or diarrhea should be brought to a doctor's attention. Seventh, this medication can lower vitamin B12 levels so it is advisable to regularly check vitamin B12 levels during prolonged use. Eighth, if symptoms such as fever, pain around the genitals or perineum, swelling, or erythema develop, they may indicate a serious infection, and immediate consultation with healthcare professionals is required. Ninth, elderly patients or those with decreased kidney function should have their kidney function regularly monitored and may require dose adjustments when taking this medication. Finally, it is advisable to avoid alcohol while taking this medication, and if hypoglycemic symptoms or other adverse reactions occur, consult a doctor immediately.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the medication's effectiveness for a longer duration.
White, film-coated, oval tablet with a yellow tint, double convex
60 tablets/box [10 tablets/PTP x 6 pieces]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.